Free Trial
Earnings Season Is Here. MarketBeat All Access for Just $149
Get the Deal
Claim MarketBeat All Access Sale Promotion

116,170 Shares in Perrigo Company plc $PRGO Acquired by TD Waterhouse Canada Inc.

Perrigo logo with Healthcare background
Image from MarketBeat Media, LLC.

Key Points

TD Waterhouse Canada Inc. acquired a new stake in shares of Perrigo Company plc (NYSE:PRGO - Free Report) in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 116,170 shares of the company's stock, valued at approximately $1,621,000. TD Waterhouse Canada Inc. owned approximately 0.08% of Perrigo as of its most recent SEC filing.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. KBC Group NV lifted its holdings in shares of Perrigo by 61.3% in the 1st quarter. KBC Group NV now owns 6,283 shares of the company's stock worth $67,000 after purchasing an additional 2,388 shares in the last quarter. Parvin Asset Management LLC acquired a new stake in Perrigo in the 2nd quarter valued at $79,000. Allworth Financial LP grew its position in Perrigo by 489.1% in the 2nd quarter. Allworth Financial LP now owns 9,390 shares of the company's stock valued at $98,000 after purchasing an additional 7,796 shares during the period. Whitebox Advisors LLC bought a new stake in Perrigo during the 1st quarter valued at $111,000. Finally, Integrated Wealth Concepts LLC bought a new stake in Perrigo during the 2nd quarter valued at $126,000. Institutional investors own 95.91% of the company's stock.

Analyst Upgrades and Downgrades

PRGO has been the topic of several research reports. Weiss Ratings upgraded shares of Perrigo from a "sell (d-)" rating to a "sell (d)" rating in a report on Thursday, August 6th. Wall Street Zen cut shares of Perrigo from a "strong-buy" rating to a "buy" rating in a report on Sunday, September 27th. One research analyst has rated the stock with a Buy rating, four have given a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat.com, the stock presently has an average rating of "Hold" and a consensus price target of $19.33.

View Our Latest Stock Report on Perrigo

Perrigo Trading Down 1.4%

Shares of Perrigo stock opened at $15.95 on Thursday. The company has a market capitalization of $2.21 billion, a P/E ratio of -1.27, a price-to-earnings-growth ratio of 1.85 and a beta of 0.69. The stock has a fifty day simple moving average of $14.47 and a 200 day simple moving average of $12.20. Perrigo Company plc has a 12-month low of $9.23 and a 12-month high of $22.02. The company has a current ratio of 2.32, a quick ratio of 1.32 and a debt-to-equity ratio of 1.31.

Perrigo (NYSE:PRGO - Get Free Report) last issued its quarterly earnings data on Wednesday, August 5th. The company reported $0.50 earnings per share for the quarter, beating the consensus estimate of $0.39 by $0.11. The business had revenue of $1.02 billion for the quarter, compared to analysts' expectations of $1.02 billion. Perrigo had a positive return on equity of 11.25% and a negative net margin of 41.85%. The business's revenue was down 3.1% on a year-over-year basis. During the same period last year, the business earned ($0.06) EPS. Perrigo has set its FY 2026 guidance at 2.250-2.550 EPS. On average, sell-side analysts anticipate that Perrigo Company plc will post 2.18 earnings per share for the current fiscal year.

Perrigo Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Tuesday, September 15th. Stockholders of record on Friday, August 28th were issued a $0.29 dividend. The ex-dividend date was Friday, August 28th. This represents a $1.16 annualized dividend and a dividend yield of 7.3%. Perrigo's dividend payout ratio is currently -9.27%.

Perrigo Company Profile

(Free Report)

Perrigo Company plc is a global consumer self-care company that develops, manufactures and markets over-the-counter health products, wellness products and personal care items. Its portfolio includes products for allergy, pain relief, digestive health, skin care, smoking cessation, women's health and other everyday health needs, along with vitamins, nutritional supplements and infant nutrition products.

Perrigo supplies products under its own brands, acquired brands and retailer-owned private-label labels.

Featured Stories

Want to see what other hedge funds are holding PRGO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Perrigo Company plc (NYSE:PRGO - Free Report).

Institutional Ownership by Quarter for Perrigo (NYSE:PRGO)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Perrigo Right Now?

Before you consider Perrigo, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Perrigo wasn't on the list.

While Perrigo currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The 7 Hottest IPO Stories of 2026 Cover

MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.

Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines